These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

79 related items for PubMed ID: 9020529

  • 1. The effect of pentagastrin, cholecystokinin and their analogues on rat arterial blood pressure and isolated heart.
    Wiśniewska R, Wiśniewski K.
    Rocz Akad Med Bialymst; 1996; 41(2):183-90. PubMed ID: 9020529
    [Abstract] [Full Text] [Related]

  • 2. Effects of cholecystokinin (CCK-33) and its fragments, C-terminal octapeptide (CCK-8) and C-terminal tetrapeptide (CCK-4), on the circulatory system of diabetic rats.
    Fiedorowicz RJ, Wiśniewski K.
    Pol J Pharmacol Pharm; 1989; 41(6):561-72. PubMed ID: 2485904
    [Abstract] [Full Text] [Related]

  • 3. Effects of cholecystokinin, caerulein and pentagastrin on arterial blood pressure and plasma renin activity in rats.
    Wiśniewska RJ.
    Pol J Pharmacol; 1997; 49(6):419-23. PubMed ID: 9566045
    [Abstract] [Full Text] [Related]

  • 4. Interaction of cholecystokinin (CCK-8) with agonist and antagonist of beta-adrenergic receptors in circulatory system of diabetic rats.
    Wiśniewska RJ, Wiśniewski K.
    Pol J Pharmacol; 1996; 48(3):293-7. PubMed ID: 9112665
    [Abstract] [Full Text] [Related]

  • 5. The influence of C-terminal cholecystokinin fragments in the circulatory system of rats.
    Wiśniewska RJ, Kupryszewski G.
    Pol J Pharmacol Pharm; 1992; 44(3):281-7. PubMed ID: 1470565
    [Abstract] [Full Text] [Related]

  • 6. The interaction of cholecystokinin and its fragments with norepinephrine in the circulatory system of diabetic rats.
    Fiedorowicz RJ, Wiśniewski K.
    Pol J Pharmacol Pharm; 1989; 41(6):573-83. PubMed ID: 2577226
    [Abstract] [Full Text] [Related]

  • 7. Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of rats. Part A.
    Wiśniewska RJ.
    Pol J Pharmacol; 1998; 50(3):203-12. PubMed ID: 9861628
    [Abstract] [Full Text] [Related]

  • 8. Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of diabetic rats. Part B.
    Wiśniewska RJ.
    Pol J Pharmacol; 1998; 50(3):213-23. PubMed ID: 9861629
    [Abstract] [Full Text] [Related]

  • 9. The influence of SPC-703 on blood pressure in rabbits and rats and on isolated heart of guinea pigs.
    Matuszek M, Gagało I, Hać E.
    Pol J Pharmacol Pharm; 1979; 31(5):455-9. PubMed ID: 547276
    [Abstract] [Full Text] [Related]

  • 10. Cardiovascular effects of cholecystokinin-4 are mediated by the cholecystokinin-B receptor subtype in the conscious guinea pig and dog.
    Fossa AA, DePasquale MJ, Morrone J, Zorn SH, Bryce D, Lowe JA, McLean S.
    J Pharmacol Exp Ther; 1997 Apr; 281(1):180-7. PubMed ID: 9103496
    [Abstract] [Full Text] [Related]

  • 11. Cardiovascular effects of secretin in intact rats versus rats with streptozotocin-induced diabetes mellitus.
    Sitniewska E, Wiśniewska RJ.
    Pol J Pharmacol; 1999 Apr; 51(2):131-6. PubMed ID: 10425641
    [Abstract] [Full Text] [Related]

  • 12. Effects of prolonged cholecystokinin administration on rat pituitary-adrenocortical axis: role of the CCK receptor subtypes 1 and 2.
    Malendowicz LK, Spinazzi R, Majchrzak M, Nowak M, Nussdorfer GG, Ziolkowska A, Macchi C, Trejter M.
    Int J Mol Med; 2003 Dec; 12(6):903-9. PubMed ID: 14612964
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Subendocardial and subepicardial pressure-flow relations in the rat heart in diastolic and systolic arrest.
    Lamberts RR, Willemsen MJ, Sipkema P, Westerhof N.
    J Biomech; 2004 May; 37(5):697-707. PubMed ID: 15046999
    [Abstract] [Full Text] [Related]

  • 18. General pharmacological profile of the novel cholecystokinin-A antagonist loxiglumide.
    Saito T, Ukai K, Masuda T, Nakagawa T, Kimura K, Fujii M, Wakatsuki K, Saeki M, Kasai H.
    Arzneimittelforschung; 1997 Dec; 47(12):1375-82. PubMed ID: 9450167
    [Abstract] [Full Text] [Related]

  • 19. Effect of central and peripheral administrations of cholecystokinin-tetrapeptide on panic-like reactions induced by stimulation of the dorsal periaqueductal grey area in the rat.
    Mongeau R, Marsden CA.
    Biol Psychiatry; 1997 Sep 01; 42(5):335-44. PubMed ID: 9276073
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.